Thyroid Function and Autoimmunity in Subfertility Women and Assisted Reproductive Therapy - Trial NCT06394466
Access comprehensive clinical trial information for NCT06394466 through Pure Global AI's free database. This phase not specified trial is sponsored by Rio de Janeiro State University and is currently Completed. The study focuses on Ovarian Failure,Thyroid Diseases. Target enrollment is 453 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Rio de Janeiro State University
Timeline & Enrollment
N/A
Jul 01, 2021
Jul 31, 2023
Primary Outcome
TSH levels during assisted reproductive therapy and first trimester
Summary
The assessment of ovarian reserve is well established based on the dosage of anti-Mullerian
 hormone (AMH). The clinical applicability of detecting thyroid autoantibodies levels has been
 discussed as a potential marker of low-grade inflammation. There are no studies about the
 detection of these autoantibodies in infertile women. Our objective is to evaluate the
 association between ovarian reserve and thyroid function and its autoimmunity in infertile
 women seeking for assisted reproductive treatment (ART).Evaluation ot thyroid function in the
 first trimester in also be evaluated in women submitted to ART.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06394466
Non-Device Trial